{
  "main_header": {
    "sid": 793005,
    "name": "Glaxosmi. Pharma",
    "stock_name": "Glaxosmi. Pharma",
    "full_name": "Glaxosmithkline Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/glaxosmi-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,596.60",
    "chg": -4.4,
    "chgp": "-0.17%",
    "dir": -1,
    "prev_price": "2,601.00",
    "mcapval": "43,952.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500660,
    "symbol": "GLAXO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE159A01016",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "8.37 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/glaxosmi-pharma-793005-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter",
        "link": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNUU95VVpOQXdRZ1ZPX0dpN29Tb0hKYnpNV0JSN285OW9HMjZ1c3YzZUxOYWoyZzV6SGctaVJsMjBKTndSeEtZY0d3eW5PQVJWTWhzYWUyTzdiZzN1dDZYUzZWNG9DN1FWTERYTlh3TlhtcGJoLXpCNFA4YTQ0VENRaV9CTEY5bzdlY3F0WU1tXzBadkZHNE1fb1RtSnEyNTNUOHVldkF4ZkdjZzJIeW54aUxEYzlSazF1MjU0YThZS3dUN2FXd0NOYklyZWhCTzFseEtVMk5BRXZsRFhqLVc0X21WV21xRmlPckNVZTIzYUJLTzc2WHJyLUk5UnFtVENOQ0pRU9IBigJBVV95cUxOSllpNGFuZTZxWHlPRnBhWi1VQkMxN3J3TnFsWEkwaTE3Y0s5eG5HdTctMWRXOGZLSEVubEltYzFHNGxLTzB2dFBIX0R1QTJGSzZMRllhTjlOcHl0cmtpYmtkWENSWGMxVVNuYTNkOFB3aVFHYTNiU1cybGlRMWE5cU44dXpSdWxSUEEtUHpZODQ3ZW5kSWVwVXBGVElRWkZZWWFwT0tES0pKeUk3X2xfTTRQeXJaTzNXbWE5Mk5QSUc0TEtab0FVU1UyUnh6amM4WHlaYmVwRkNiZFlxbERyUURXLWFnX0phNWdXcE45WnNnTDVyNjFYZTFhakxUZkFaNS1RSUZzcVA3QQ?oc=5",
        "imagepath": "",
        "date": "2026-08-03 16:55:28",
        "description": "Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter  Business Standard..."
      },
      {
        "title": "Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 11:32:00",
        "description": "Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter  Business Standard..."
      }
    ],
    "total": 2,
    "sid": "793005",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/glaxosmithkline-pharmaceuticals-793005"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "06-Aug-2026",
      "details": "Transcript",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30",
      "datetime": "06-Aug-2026",
      "details": "IT Refund of Rs 52 crores",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Aug-2026",
      "details": "As per attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has declared <strong>570%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Sep 18",
          "dt": "2018-09-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

2026-08-03 16:55:28

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter Business Standard...

Read More

Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter

2026-07-06 11:32:00

Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter Business Standard...

Read More

View All News